Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Sullivan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|February 12, 2013
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9Ekambar R Kandimalla, Lakshmi Bhagat, Daqing Wang, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework RecommendationEmuella Flood, Niklas Karlsson, Jennifer Ostridge, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640Eric C Lacasse, Ekambar R Kandimalla, Peter Winocour, et al.
Journal of Orthopaedics|October 16, 2023
Predictors of in-hospital surgical site infections in surgically managed acetabular fractures: A nationwide analysisJustin M Lapow, Antonio Lobao, Jason Kreinces, et al.
Free Radical Biology & Medicine|June 1, 2013
Nrf2 activation: a potential strategy for the prevention of acute mountain sicknessChristina Lisk, Joe McCord, Swapan Bose, et al.
Psychopharmacology|September 15, 2004
Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behaviorAndrew Holmes, Qian Li, Elizabeth A Koenig, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha inductionDong Yu, Mallikarjuna R Putta, Lakshmi Bhagat, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of a series of quinazolinone-derived antagonists of CXCR3Jiwen Liu, Zice Fu, An-Rong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2005
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonistsEkambar R Kandimalla, Lakshmi Bhagat, Yukui Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2009
Discovery and optimization of CRTH2 and DP dual antagonistsJiwen Liu, Zice Fu, Yingcai Wang, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|February 12, 2013
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9Ekambar R Kandimalla, Lakshmi Bhagat, Daqing Wang, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework RecommendationEmuella Flood, Niklas Karlsson, Jennifer Ostridge, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640Eric C Lacasse, Ekambar R Kandimalla, Peter Winocour, et al.
Journal of Orthopaedics|October 16, 2023
Predictors of in-hospital surgical site infections in surgically managed acetabular fractures: A nationwide analysisJustin M Lapow, Antonio Lobao, Jason Kreinces, et al.
Free Radical Biology & Medicine|June 1, 2013
Nrf2 activation: a potential strategy for the prevention of acute mountain sicknessChristina Lisk, Joe McCord, Swapan Bose, et al.
Psychopharmacology|September 15, 2004
Phenotypic assessment of galanin overexpressing and galanin receptor R1 knockout mice in the tail suspension test for depression-related behaviorAndrew Holmes, Qian Li, Elizabeth A Koenig, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha inductionDong Yu, Mallikarjuna R Putta, Lakshmi Bhagat, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of a series of quinazolinone-derived antagonists of CXCR3Jiwen Liu, Zice Fu, An-Rong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2005
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonistsEkambar R Kandimalla, Lakshmi Bhagat, Yukui Li, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2009
Discovery and optimization of CRTH2 and DP dual antagonistsJiwen Liu, Zice Fu, Yingcai Wang, et al.
Pageof 3